发明名称 Potential cardiotoxicity of compounds predicted based on the interaction of astemizole with the HERG (human ether-a-go-go-related gene) potassium channel
摘要 Assays and kits are provided for the screening of test compounds for their capability to induce cardiotoxicity in a subject. The assays and kits are based on the finding that the interaction of astemizole with the HERG (Human Ether-a-go-go-Related Gene) potassium channel can be exploited to predict cardiotoxicity of compounds during the development of new therapeutics and other agents. Figure 1 A shows the saturation binding of [3H]-astemizole to cell membrane preparations of HEK293 cells stably transfected with the HERG channel cDNA. TB represents Total Binding measured, NSB represents Non Specific Binding measured and SB represents Specific Binding measured.
申请公布号 NZ529496(A) 申请公布日期 2005.09.30
申请号 NZ20020529496 申请日期 2002.07.02
申请人 JANSSEN PHARMACEUTICA N 发明人 HEYLEN, GODELIEVE IRMA CHRISTINE MARIA;JANSSEN, CORNELUS GERARDUS MARIA;JURZAK, MIREK ROMAN;VAN ASSOUW, HENRICUS PETRUS MARTINUS MARIA;VAN ZON, MARGOT
分类号 C07D401/12;C07K14/47;C12N5/10;C12N15/09;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50;G01N33/60;G01N33/68;(IPC1-7):G01N33/50 主分类号 C07D401/12
代理机构 代理人
主权项
地址